Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesfetal-neonatal-and-perinatal

Paeds Cases · fetal-neonatal-and-perinatal

The preterm infant who stops weaning — a haemodynamically significant PDA

OSCE on a ventilated preterm infant with a haemodynamically significant patent ductus arteriosus, testing the assessment of significance, the expectant-first management ladder, the drug doses, the trial evidence, and the exclusion of a duct-dependent circulation.

osce neonatal haemodynamics scenario3 min readVerification in progress

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
On this page
Study tools

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
Prompt
A 26-week, 780 g infant at day 5 of life, ventilated for respiratory distress syndrome and previously weaning, develops bounding pulses, a hyperdynamic precordium, a widened pulse pressure of 52/24, oliguria and a creeping oxygen requirement; the candidate must assess haemodynamic significance, integrate the clinical and echocardiographic findings, institute expectant management, state the indications and doses for pharmacological closure, and exclude a duct-dependent circulation before any treatment.
Candidate brief

You are the neonatal registrar. A 26-week, 780 g infant (day 5, ventilated for respiratory distress syndrome and previously weaning) has developed bounding pulses, a hyperdynamic precordium and a widened pulse pressure (52/24), with the urine output falling to 0.8 mL/kg/h and the oxygen requirement creeping from 28% to 42%. [13] You have four minutes to assess the significance of the duct, state your immediate and stepwise management, give the drug doses you would use, and explain the safety check before any closure attempt.

Clinical information for the examiner

Setting: Tertiary NICU, day 5 of life. The infant is ventilated on volume-targeted ventilation (PIP 16, PEEP 5, rate 30, FiO₂ 0.42) for respiratory distress syndrome; antenatal steroids were given and one dose of surfactant administered at birth. The creatinine has risen from 78 to 102 µmol/L. [13]

On your arrival:

  • Heart rate 158, SpO₂ 92%, blood pressure 52/24 (mean 34), widened pulse pressure 28. [13]
  • Pulses bounding at the brachial and femoral arteries; precordium hyperdynamic. [13]
  • Soft systolic murmur at the upper left sternal border. [13]
  • Urine output 0.8 mL/kg/h (was 2.5). [13]

Functional echocardiogram (provided): structurally normal heart; duct diameter 2.1 mm with left-to-right flow; left atrial-to-aortic root ratio 1.7; diastolic flow reversal in the descending aorta; increased left ventricular output. [13]

This is a haemodynamically significant PDA

The widened pulse pressure with a low diastolic, the bounding pulses and hyperdynamic precordium, the oliguria and rising creatinine, and the echo constellation (duct over 1.5 mm, LA:Ao over 1.5, aortic diastolic flow reversal) together define a haemodynamically significant PDA. [13] The candidate must integrate the clinical end-organ signs with the echo and exclude a duct-dependent circulation before any treatment.

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Hundscheid T, Onland W, Kooi EMW, et al Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N Engl J Med, 2023.PMID 36477458
  2. [2]Mitra S, Florez ID, Tamayo ME, et al Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis. JAMA, 2018.PMID 29584842
  3. [4]Jasani B, Mitra S, Shah PS Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev, 2022.PMID 36519620
  4. [6]Clyman RI, Liebowitz M, Kaempf J, et al PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr, 2019.PMID 30340932
  5. [10]Weisz DE, McNamara PJ Patent ductus arteriosus ligation and adverse outcomes: causality or bias? J Clin Neonatol, 2014.PMID 25024972
  6. [13]Mitra S, Weisz D, Jain A, et al Management of the patent ductus arteriosus in preterm infants. Paediatr Child Health, 2022.PMID 35273674
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousThe opioid-exposed newborn with evolving withdrawal — methadone maintenancefetal-neonatal-and-perinatalNextThe surgical newborn — bilious vomiting with a double-bubblefetal-neonatal-and-perinatal